N/A
N=11
Evaluation of Procedural Analgesia for Liposonix Treatment
Body Contouring
Bottom Line
View on ClinicalTrials.gov: NCT01993238 ↗Enrolled (actual)
11
Serious AEs
9.1%
Results posted
Apr 2014
Primary outcome: Primary: Pain Score for Overall Treatment — 6.3 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Liposonix System (Model 2) (Device); Pre-treatment analgesia (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Solta Medical
- Primary completion
- Jan 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain Score for Overall Treatment |
6.3 | — |
| SECONDARY Safety Assessment |
— | — |
| SECONDARY Pain Scores Reported at 1-day Post-Treatment |
2.1 | — |
Summary
The objectives of this study are to evaluate the safety and effectiveness of procedural analgesia for improvements in tolerability of treatment with the Liposonix System.
Eligibility Criteria
Inclusion Criteria
- Subject is an adult female or male, 18 to 65 years of age.
- Subject must weigh more than 120 pounds.
- Subject must have a Body Mass Index of ≤ 30 kg/m2.
- Subject must have thickness of skin + subcutaneous adipose tissue in the anticipated treatment area of ≥ 2.3 cm.
- Subject must be able to read, write, speak, and understand English.
Exclusion Criteria
- Female subject who is pregnant, is suspected to be pregnant, or is lactating
- Subjects diagnosed with coagulation disorders or are receiving anticoagulant therapy or medications or dietary supplements which impede coagulation or platelet aggregation
- Subject has diabetes or cardiovascular disease
- Subject has had any aesthetic procedure to the region to be treated within past 6 months
- Subject has systemic skin disease or skin disease in the area to be treated
- Subject has any abnormality of the skin or soft tissues of the abdominal wall in the area to be treated
- Subject has had previous open or laparoscopic surgery in the anticipated treatment area
- Subjects is on prescription or over the counter weight reduction medication or programs, or had weight reduction procedures
- Subject has skin or superficial tissue that does not lie flat on its own when the subject is in the supine position
- Subjects undergoing chronic steroid or immunosuppressive therapy
- Subjects who have cardiac pacemakers or any implantable electrical device
- Subjects who have metal implants of any type in the area to be treated
- History of cancer
- Subjects who have sensory loss or dysesthesia in the area to be treated
- Subjects taking chronic benzodiazepines or opiates
- Subjects with a history of severe nausea/vomiting with opioid analgesics
- Subjects with sleep apnea
- Subjects with known allergies or sensitivities to study drugs
- Subjects with liver disease
- Subjects with renal failure
Data sourced from ClinicalTrials.gov (NCT01993238). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.